Abstract

Irradiation is widely used in anticancer therapy; however, the efficiency is limited. Most cancer cells have mutations in apoptosis that they can easily escape the apoptosis induced by irradiation. Autophagy has been known as type II programmed cell death that can be activated by irradiation, especially when apoptosis is blocked, but the underlying molecular mechanism is largely unknown. We demonstrated that proapoptotic genes PUMA and Bid are involved in the regulation of autophagic cell death. When wild-type (WT), Bax−/− and PUMA−/− HCT116 cells were exposed to irradiation, we found that, compared with WT, Bax−/− cells showed significantly decreased cell death because of Bax deficiency; however, surprisingly PUMA−/− cells showed significant increase in cell death although the proapoptotic gene PUMA was knocked out. By analyzing apoptosis via Annexin V-fluorescein isothiocyanate (FITC) assay with flow cytometry, both Bax−/− and PUMA−/− cells showed less apoptosis than WT, suggesting the existence of another type of cell death in PUMA−/− cells. Autophagy was then examined in three cell lines by counting the percentage of cells with punctate GFP-LC3. Although all three cell lines showed significantly increased autophagy activity after irradiation, that of PUMA−/− cells was much higher than the other two cell lines, which suggests that PUMA−/− cells may die through autophagy. This was then confirmed by the decreased cell death in PUMA−/− cells when autophagy was blocked by 3-MA. In addition, we also tested the responses of WT and Bid−/− MEFs to irradiation. Bid−/− MEFs but not WT died through autophagy after irradiation. These results imply the involvement of apoptosis-associated genes such as PUMA and Bid in autophagic cell death, which contributes to identifying the molecular mechanism by which autophagy drives cells to death.

Highlights

  • Radiotherapy (RT) has been importantly involved in anticancer treatments

  • In order to elucidate the mechanism by which autophagy leads with punctate GFP after irradiation (Figures 3a and b), indicating to cell death, we investigated the response of three isogenic human colon cancer cell lines: WT, Bax− / −, and PUMA− / − HCT116, that autophagy was induced by irradiation in all three cell lines

  • It is known that the role of autophagy being pro-survival or prodeath is cell line and context dependent, so in order to test whether the autophagic cell death induced by irradiation is HCT116 cell specific or PUMA knockout specific, we introduced another BH3-only-protein-deficient cell line Bid− / − MEF cells into the model

Read more

Summary

Introduction

Radiotherapy (RT) has been importantly involved in anticancer treatments. Around 50% of cancer patients receive RT at some stage of their treatment, alone or in combination with other treatments such as surgery and/or chemotherapy.[1,2,3,4] Ionizing radiation (IR) is the most commonly used RT, which mainly causes damage by DNA double-strand breaks leading to cell death.[5] IR successfully helped local control and increased overall survival.[2,6,7] IR is limited and shows poor effect in a significant proportion of high-risk patients who may develop metastasis in several years,[8,9] which cannot be resolved by further dose escalation because of toxicity to adjacent normal tissues. The resistance of cancer cells to IR causes treatment failure too. Exploring novel targeted agents to augment the efficiency of RT is in need

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call